Verzistobart | m-entrepreneurship.com

Product Name :
Verzistobart

Search keywords :
Verzistobart

drugId :
null

Target Vo:
Hepatitis A virus cellular receptor 2

Target Vo Short Name :
HAVCR2

Moa_Name:
Hepatitis A virus cellular receptor 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Agenus Inc

Active Company_Name :
Incyte Biosciences International Sàrl

Active Indication_Name:
Carcinoma, Merkel Cell

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Guselkumab Cancer
CD81 Rabbit mAb Epigenetic Reader Domain
NQO1 Antibody (YA697): NQO1 Antibody (YA697) is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to NQO1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts